2006
DOI: 10.1097/00126869-200634010-00015
|View full text |Cite
|
Sign up to set email alerts
|

Toxicity of Local Anesthetics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 55 publications
0
5
0
Order By: Relevance
“…14,27e29 Based on the evidence provided on possible chondrocyte viability and its safety and efficacy, a standard dose of bupivacaine (0.25% without epinephrine) was considered a safe method to provide postoperative pain control. 28 Our data analysis of FPS-R and opioid consumption, measured as morphine equivalents, showed that both groups used similar amounts of postoperative pain medication and does not favor the use of local hematoma to decrease the need for opioid use on postoperative day 1 in pediatric SHF after patients undergo closed reduction percutaneous pin fixation. It is unclear at this stage whether results would differ with greater power; our results should be validated in a larger sample.…”
Section: Discussionmentioning
confidence: 73%
See 2 more Smart Citations
“…14,27e29 Based on the evidence provided on possible chondrocyte viability and its safety and efficacy, a standard dose of bupivacaine (0.25% without epinephrine) was considered a safe method to provide postoperative pain control. 28 Our data analysis of FPS-R and opioid consumption, measured as morphine equivalents, showed that both groups used similar amounts of postoperative pain medication and does not favor the use of local hematoma to decrease the need for opioid use on postoperative day 1 in pediatric SHF after patients undergo closed reduction percutaneous pin fixation. It is unclear at this stage whether results would differ with greater power; our results should be validated in a larger sample.…”
Section: Discussionmentioning
confidence: 73%
“… 26 Furthermore, bupivacaine has a more rapid, profound, and effective (3 to 4 times) anesthetic effect on soft tissues and bones than lidocaine, as well as a longer half-life (2.7–8.1 hours vs 1.5–2 hours). 14 , 27 , 28 , 29 Based on the evidence provided on possible chondrocyte viability and its safety and efficacy, a standard dose of bupivacaine (0.25% without epinephrine) was considered a safe method to provide postoperative pain control. 28 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…With the exception of bupivacaine, cardiovascular toxicity becomes evident after plasma levels have compromised the central nervous system. Cardiovascular toxicity is manifested by arrhythmias and refractory myocardial depression, especially when the agent used is bupivacaine 28 . Toxic doses are capable of inhibiting sinoatrial and atrioventricular node conduction, prolonging the PR space, widening the QRS complex, generating atrioventricular blocks of varying degrees and arrhythmias, both bradycardias and reentrant tachyarrhythmias with ventricular tachycardia or fibrillation 11 .…”
Section: Local Anesthetic Toxicitymentioning
confidence: 99%
“…Bupivacaine is bound predominantly to open and inactive Na+ channels, which may justify the severity of toxicity. Myocardial depression occurs because of several factors: inhibition of Ca++ release in the sarcoplasmic reticulum by blockade of β-adrenergic receptors, decreasing adenylate cyclase activity by reducing the synthesis of cyclic adenosine monophosphate and the conversion of ADP into ATP 28 .…”
Section: Local Anesthetic Toxicitymentioning
confidence: 99%